Articles about Biotech – Page 4 of 8

Alexandria doubles down on decades-long Seattle biotech bet with Mercer ‘Mega Block’ deal

As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is… Read More

Gov. Inslee helps Bluebird Bio open new ‘nest’ for cancer research efforts in Seattle

Bluebird Bio is growing its nest in Seattle. The leading biotech company held a ribbon-cutting event Friday to celebrate the… Read More

‘Mega Block’ in Amazon’s backyard will become a life sciences campus following $143.5M deal; proceeds to fund affordable housing

One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into… Read More

Seattle biotech startup OncoSenX raises $3M to develop tumor-killing therapeutics

Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline… Read More

Isilon co-founder Sujal Patel building mysterious biotech startup, backed by Andreessen Horowitz

Sujal Patel has seen a world-changing trend coming before. In 2001, in his mid-20s, he founded data storage technology company… Read More

Bristol-Myers Squibb exec on how can Seattle grow — and keep — big biotech companies

Henrik Andersen, head of biologics development at Bristol-Myers Squibb, knows what it’s like to be at a hot biotech when… Read More

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

The Fred Hutchinson Cancer Research Center has a historic new signpost on Seattle’s Lake Union. The institution has started adding… Read More

Just Biotherapeutics, backed by Gates Foundation, snapped up by German biotech firm for up to $90M

Just Biotherapeutics, a Seattle-based company that aims to reduce the cost of protein drug development, announced an agreement Monday to… Read More

Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial

Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has… Read More

How scorpion venom helps improve brain cancer surgery in children by making tumors glow

Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial for its “Tumor Paint,”… Read More

Seattle biotech startup Good Therapeutics raises $11M to make smart cancer therapies

Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11… Read More

Digital health investments hit an all-time high of $8.6B in 2018

Big deals led to a banner year for U.S. digital health investments, which shot up 21 percent to $8.6 billion… Read More

New Seattle startup emerges from UW to develop cancer-fighting protein three decades in the making

For 30 years, scientists have been trying to unleash the promise of Interleukin-2 (IL-2), a powerful protein that fights cancer… Read More

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion

Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More

Seattle biotech startup raises $20M to develop gene therapy technology

Seattle-based biotech startup Immusoft this week closed a $20 million Series B venture capital round that will fuel development of… Read More

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More

Cancer drug maker CTI BioPharma lays off 50% of workforce

CTI BioPharma announced Thursday that it will let go of half its employees in order to create more runway to… Read More

Seattle biotech startup raises $3.7M to help the body regenerate tissue

Rodeo Therapeutics, a Seattle-based biotech startup that is creating therapies to help the body regenerate tissue, has landed $3.7 million… Read More

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

As a journalist, Luke Timmerman has covered biotech for more than 17 years. Now, the Timmerman Report founder is making… Read More

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More

Seattle Genetics drug rides FDA fast-track to the front lines in fight against rare form of cancer

Seattle Genetics’ star cancer drug Adcetris has won Food and Drug Administration approval for treatment of a fast-growing type of… Read More

Secretive startup Receptor Life Sciences raises $7.5M for therapies based on ‘plant extracts’

Secretive biotechnology company Receptor Life Sciences has raised a funding round totaling just over $7.5 million, according to a filing with… Read More

Can you live to 200? New podcast from Seattle entrepreneur T.A. McCann wants to find out

Life expectancy worldwide has more than doubled since the year 1900. Thanks to remarkable scientific breakthroughs, people today are living… Read More

Grail raises $300M for cancer detection tools, boosting total investment to $1.5B

News Brief: Grail, a biotech company with early backing from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, says… Read More

New office project in Amazon’s backyard could be welcome news for space-hungry biotech industry

A big new project near Amazon’s Seattle headquarters could provide some relief to biotech and life sciences companies searching the… Read More

Astellas Pharma buying Universal Cells for $102M in Seattle’s third biotech acquisition in a month

Astellas Pharma, a Japanese pharmaceutical and biotechnology company, is acquiring Seattle biotech Universal Cells. Astellas will pay up to $102.5… Read More

Gene therapy startup Immusoft raises $3M, appoints new CEO as it approaches clinical trials

Immusoft is looking to get its gene therapy technology into clinical trials, and the Seattle startup announced Friday that it… Read More

Feeling blue? Biotech startup raises $13M to create ‘natural’ color pigments using algae

We all love a splash of color in our lives, but we seldom realize the technology that goes into the… Read More

Seattle Genetics beats earnings expectations as lead drug Adcetris finds market success

Seattle Genetics, the maker of cancer drug Adcetris, beat analyst expectations by a noticeable margin in its third-quarter earnings, reported… Read More

Seattle Children’s licenses gene-editing therapy to Casebia Therapeutics and will partner on further research

The Seattle Children’s Research Institute announced Wednesday that it has licensed a new gene therapy technology to Cambridge, Mass.,-based biotech company… Read More